nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—Progesterone—uterine cancer	0.405	1	CrCtD
Prednisolone—NR3C2—Progesterone—uterine cancer	0.0984	0.416	CbGbCtD
Prednisolone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.049	0.207	CbGbCtD
Prednisolone—NR3C1—Progesterone—uterine cancer	0.0325	0.137	CbGbCtD
Prednisolone—CYP2A6—Progesterone—uterine cancer	0.0227	0.0957	CbGbCtD
Prednisolone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0193	0.065	CrCrCtD
Prednisolone—Potassium Canrenoate—Progesterone—uterine cancer	0.0168	0.0566	CrCrCtD
Prednisolone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.0163	0.0549	CrCrCtD
Prednisolone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0152	0.051	CrCrCtD
Prednisolone—Medrysone—Progesterone—uterine cancer	0.0142	0.0478	CrCrCtD
Prednisolone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.0142	0.0477	CrCrCtD
Prednisolone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.0137	0.0462	CrCrCtD
Prednisolone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0133	0.0449	CrCrCtD
Prednisolone—Hydrocortamate—Progesterone—uterine cancer	0.0124	0.0416	CrCrCtD
Prednisolone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0123	0.0412	CrCrCtD
Prednisolone—Cortisone acetate—Progesterone—uterine cancer	0.012	0.0403	CrCrCtD
Prednisolone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0402	CrCrCtD
Prednisolone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0119	0.0402	CrCrCtD
Prednisolone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0116	0.0392	CrCrCtD
Prednisolone—Testolactone—Progesterone—uterine cancer	0.0116	0.0391	CrCrCtD
Prednisolone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0111	0.0373	CrCrCtD
Prednisolone—Fluoxymesterone—Progesterone—uterine cancer	0.0107	0.036	CrCrCtD
Prednisolone—Fludrocortisone—Progesterone—uterine cancer	0.0104	0.035	CrCrCtD
Prednisolone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0349	CrCrCtD
Prednisolone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0349	CrCrCtD
Prednisolone—Methyltestosterone—Progesterone—uterine cancer	0.0101	0.0341	CrCrCtD
Prednisolone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00974	0.0328	CrCrCtD
Prednisolone—Testosterone—Progesterone—uterine cancer	0.00903	0.0304	CrCrCtD
Prednisolone—Hydrocortisone—Progesterone—uterine cancer	0.00849	0.0286	CrCrCtD
Prednisolone—ABCB1—Progesterone—uterine cancer	0.00756	0.032	CbGbCtD
Prednisolone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00684	0.0289	CbGbCtD
Prednisolone—ABCB1—Dactinomycin—uterine cancer	0.006	0.0253	CbGbCtD
Prednisolone—CYP3A4—Progesterone—uterine cancer	0.00453	0.0191	CbGbCtD
Prednisolone—ABCB1—Etoposide—uterine cancer	0.00338	0.0143	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—uterine cancer	0.00231	0.00975	CbGbCtD
Prednisolone—SERPINA6—oviduct—uterine cancer	0.00205	0.178	CbGeAlD
Prednisolone—CYP3A4—Etoposide—uterine cancer	0.00203	0.00857	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—uterine cancer	0.00138	0.00584	CbGbCtD
Prednisolone—NR3C2—myometrium—uterine cancer	0.000535	0.0466	CbGeAlD
Prednisolone—SERPINA6—renal system—uterine cancer	0.000477	0.0415	CbGeAlD
Prednisolone—NR3C2—uterine cervix—uterine cancer	0.000416	0.0363	CbGeAlD
Prednisolone—NR3C2—smooth muscle tissue—uterine cancer	0.000405	0.0352	CbGeAlD
Prednisolone—NR3C2—renal system—uterine cancer	0.000389	0.0339	CbGeAlD
Prednisolone—SERPINA6—female reproductive system—uterine cancer	0.000382	0.0333	CbGeAlD
Prednisolone—NR3C2—endometrium—uterine cancer	0.000376	0.0328	CbGeAlD
Prednisolone—NR3C2—mammalian vulva—uterine cancer	0.000364	0.0317	CbGeAlD
Prednisolone—NR3C2—uterus—uterine cancer	0.000347	0.0302	CbGeAlD
Prednisolone—SLCO1A2—renal system—uterine cancer	0.000334	0.0291	CbGeAlD
Prednisolone—NR3C2—female reproductive system—uterine cancer	0.000312	0.0272	CbGeAlD
Prednisolone—CYP2A6—vagina—uterine cancer	0.000301	0.0262	CbGeAlD
Prednisolone—NR3C1—myometrium—uterine cancer	0.000287	0.025	CbGeAlD
Prednisolone—NR3C2—female gonad—uterine cancer	0.000284	0.0247	CbGeAlD
Prednisolone—NR3C2—vagina—uterine cancer	0.000282	0.0246	CbGeAlD
Prednisolone—Exemestane—CYP19A1—uterine cancer	0.000235	0.17	CrCbGaD
Prednisolone—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00498	CcSEcCtD
Prednisolone—NR3C1—epithelium—uterine cancer	0.000225	0.0196	CbGeAlD
Prednisolone—Testolactone—CYP19A1—uterine cancer	0.000224	0.162	CrCbGaD
Prednisolone—NR3C1—uterine cervix—uterine cancer	0.000223	0.0194	CbGeAlD
Prednisolone—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.000223	0.0049	CcSEcCtD
Prednisolone—Abdominal distension—Progesterone—uterine cancer	0.000217	0.00478	CcSEcCtD
Prednisolone—NR3C1—smooth muscle tissue—uterine cancer	0.000217	0.0189	CbGeAlD
Prednisolone—Leukoderma—Doxorubicin—uterine cancer	0.000215	0.00473	CcSEcCtD
Prednisolone—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.000214	0.00472	CcSEcCtD
Prednisolone—NR3C1—decidua—uterine cancer	0.000213	0.0185	CbGeAlD
Prednisolone—Sweating increased—Progesterone—uterine cancer	0.00021	0.00463	CcSEcCtD
Prednisolone—NR3C1—renal system—uterine cancer	0.000209	0.0182	CbGeAlD
Prednisolone—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.000207	0.00457	CcSEcCtD
Prednisolone—NR3C1—endometrium—uterine cancer	0.000202	0.0176	CbGeAlD
Prednisolone—Pain—Carboplatin—uterine cancer	0.0002	0.0044	CcSEcCtD
Prednisolone—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.000199	0.00439	CcSEcCtD
Prednisolone—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00434	CcSEcCtD
Prednisolone—Weight increased—Progesterone—uterine cancer	0.000196	0.00433	CcSEcCtD
Prednisolone—NR3C1—mammalian vulva—uterine cancer	0.000195	0.017	CbGeAlD
Prednisolone—Embolism venous—Epirubicin—uterine cancer	0.000195	0.0043	CcSEcCtD
Prednisolone—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00419	CcSEcCtD
Prednisolone—Neuropathy peripheral—Progesterone—uterine cancer	0.000188	0.00415	CcSEcCtD
Prednisolone—Hypernatraemia—Epirubicin—uterine cancer	0.000187	0.00413	CcSEcCtD
Prednisolone—Conjunctivitis—Progesterone—uterine cancer	0.000187	0.00412	CcSEcCtD
Prednisolone—NR3C1—uterus—uterine cancer	0.000186	0.0162	CbGeAlD
Prednisolone—NR3C2—lymph node—uterine cancer	0.000182	0.0159	CbGeAlD
Prednisolone—Embolism venous—Doxorubicin—uterine cancer	0.000181	0.00398	CcSEcCtD
Prednisolone—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.000178	0.00392	CcSEcCtD
Prednisolone—Haemoglobin—Progesterone—uterine cancer	0.000173	0.00382	CcSEcCtD
Prednisolone—Hypernatraemia—Doxorubicin—uterine cancer	0.000173	0.00382	CcSEcCtD
Prednisolone—Haemorrhage—Progesterone—uterine cancer	0.000173	0.0038	CcSEcCtD
Prednisolone—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.00379	CcSEcCtD
Prednisolone—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00376	CcSEcCtD
Prednisolone—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00376	CcSEcCtD
Prednisolone—NR3C1—female reproductive system—uterine cancer	0.000167	0.0146	CbGeAlD
Prednisolone—Visual impairment—Progesterone—uterine cancer	0.000166	0.00367	CcSEcCtD
Prednisolone—Neuropathy—Etoposide—uterine cancer	0.000165	0.00364	CcSEcCtD
Prednisolone—Optic neuritis—Epirubicin—uterine cancer	0.00016	0.00353	CcSEcCtD
Prednisolone—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.000159	0.00351	CcSEcCtD
Prednisolone—CYP3A4—renal system—uterine cancer	0.000158	0.0138	CbGeAlD
Prednisolone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000157	0.00346	CcSEcCtD
Prednisolone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.00345	CcSEcCtD
Prednisolone—ABCB1—myometrium—uterine cancer	0.000154	0.0134	CbGeAlD
Prednisolone—Embolism—Epirubicin—uterine cancer	0.000154	0.00338	CcSEcCtD
Prednisolone—NR3C1—female gonad—uterine cancer	0.000152	0.0133	CbGeAlD
Prednisolone—Keratitis—Epirubicin—uterine cancer	0.000152	0.00335	CcSEcCtD
Prednisolone—NR3C1—vagina—uterine cancer	0.000151	0.0132	CbGeAlD
Prednisolone—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000151	0.00332	CcSEcCtD
Prednisolone—Erythema—Progesterone—uterine cancer	0.00015	0.00331	CcSEcCtD
Prednisolone—Optic neuritis—Doxorubicin—uterine cancer	0.000148	0.00327	CcSEcCtD
Prednisolone—Embolism—Doxorubicin—uterine cancer	0.000142	0.00313	CcSEcCtD
Prednisolone—Vision blurred—Progesterone—uterine cancer	0.000142	0.00312	CcSEcCtD
Prednisolone—Cardiac failure congestive—Etoposide—uterine cancer	0.000141	0.0031	CcSEcCtD
Prednisolone—Keratitis—Doxorubicin—uterine cancer	0.000141	0.0031	CcSEcCtD
Prednisolone—Ill-defined disorder—Progesterone—uterine cancer	0.000139	0.00307	CcSEcCtD
Prednisolone—Hepatomegaly—Epirubicin—uterine cancer	0.000139	0.00307	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000138	0.0409	CbGpPWpGaD
Prednisolone—Angioedema—Progesterone—uterine cancer	0.000137	0.00303	CcSEcCtD
Prednisolone—Blister—Epirubicin—uterine cancer	0.000137	0.00301	CcSEcCtD
Prednisolone—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.003	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—uterine cancer	0.000136	0.0403	CbGpPWpGaD
Prednisolone—Malaise—Progesterone—uterine cancer	0.000136	0.00299	CcSEcCtD
Prednisolone—Vertigo—Progesterone—uterine cancer	0.000135	0.00298	CcSEcCtD
Prednisolone—Syncope—Progesterone—uterine cancer	0.000135	0.00297	CcSEcCtD
Prednisolone—Dermatitis atopic—Epirubicin—uterine cancer	0.000133	0.00293	CcSEcCtD
Prednisolone—Loss of consciousness—Progesterone—uterine cancer	0.000132	0.00291	CcSEcCtD
Prednisolone—Neuritis—Epirubicin—uterine cancer	0.000132	0.00291	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Etoposide—uterine cancer	0.000132	0.00291	CcSEcCtD
Prednisolone—Convulsion—Progesterone—uterine cancer	0.00013	0.00287	CcSEcCtD
Prednisolone—Hypertension—Progesterone—uterine cancer	0.00013	0.00286	CcSEcCtD
Prednisolone—Hepatomegaly—Doxorubicin—uterine cancer	0.000129	0.00284	CcSEcCtD
Prednisolone—Betamethasone—PGR—uterine cancer	0.000128	0.0927	CrCbGaD
Prednisolone—Blister—Doxorubicin—uterine cancer	0.000127	0.00279	CcSEcCtD
Prednisolone—CYP3A4—female reproductive system—uterine cancer	0.000127	0.011	CbGeAlD
Prednisolone—Discomfort—Progesterone—uterine cancer	0.000126	0.00279	CcSEcCtD
Prednisolone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000126	0.00278	CcSEcCtD
Prednisolone—Abscess—Epirubicin—uterine cancer	0.000125	0.00275	CcSEcCtD
Prednisolone—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000124	0.00274	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—HMGA1—uterine cancer	0.000124	0.0369	CbGpPWpGaD
Prednisolone—Dermatitis atopic—Doxorubicin—uterine cancer	0.000123	0.00272	CcSEcCtD
Prednisolone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000123	0.00271	CcSEcCtD
Prednisolone—Oedema—Progesterone—uterine cancer	0.000123	0.0027	CcSEcCtD
Prednisolone—Anaphylactic shock—Progesterone—uterine cancer	0.000123	0.0027	CcSEcCtD
Prednisolone—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.0027	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—uterine cancer	0.000122	0.00269	CcSEcCtD
Prednisolone—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.00269	CcSEcCtD
Prednisolone—Stinging—Epirubicin—uterine cancer	0.000122	0.00268	CcSEcCtD
Prednisolone—Cardiac arrest—Etoposide—uterine cancer	0.000121	0.00267	CcSEcCtD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000121	0.036	CbGpPWpGaD
Prednisolone—Shock—Progesterone—uterine cancer	0.000121	0.00266	CcSEcCtD
Prednisolone—ABCB1—epithelium—uterine cancer	0.000121	0.0105	CbGeAlD
Prednisolone—Petechiae—Epirubicin—uterine cancer	0.00012	0.00264	CcSEcCtD
Prednisolone—Tachycardia—Progesterone—uterine cancer	0.00012	0.00264	CcSEcCtD
Prednisolone—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.00264	CcSEcCtD
Prednisolone—ABCB1—uterine cervix—uterine cancer	0.00012	0.0104	CbGeAlD
Prednisolone—Hyperhidrosis—Progesterone—uterine cancer	0.000119	0.00261	CcSEcCtD
Prednisolone—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000118	0.0026	CcSEcCtD
Prednisolone—Abscess—Doxorubicin—uterine cancer	0.000115	0.00254	CcSEcCtD
Prednisolone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.00252	CcSEcCtD
Prednisolone—ABCB1—decidua—uterine cancer	0.000114	0.00992	CbGeAlD
Prednisolone—Stinging—Doxorubicin—uterine cancer	0.000113	0.00248	CcSEcCtD
Prednisolone—ABCB1—renal system—uterine cancer	0.000112	0.00974	CbGeAlD
Prednisolone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.00245	CcSEcCtD
Prednisolone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.00245	CcSEcCtD
Prednisolone—Insomnia—Progesterone—uterine cancer	0.000111	0.00244	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—uterine cancer	0.000111	0.00244	CcSEcCtD
Prednisolone—Paraesthesia—Progesterone—uterine cancer	0.00011	0.00243	CcSEcCtD
Prednisolone—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000109	0.00241	CcSEcCtD
Prednisolone—Viral infection—Epirubicin—uterine cancer	0.000109	0.0024	CcSEcCtD
Prednisolone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000108	0.00239	CcSEcCtD
Prednisolone—Arthropathy—Epirubicin—uterine cancer	0.000108	0.00239	CcSEcCtD
Prednisolone—ABCB1—endometrium—uterine cancer	0.000108	0.00942	CbGeAlD
Prednisolone—Sweating increased—Etoposide—uterine cancer	0.000107	0.00237	CcSEcCtD
Prednisolone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000107	0.00237	CcSEcCtD
Prednisolone—SLCO1A2—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.000107	0.0318	CbGpPWpGaD
Prednisolone—Herpes simplex—Epirubicin—uterine cancer	0.000107	0.00236	CcSEcCtD
Prednisolone—Erythema—Dactinomycin—uterine cancer	0.000106	0.00234	CcSEcCtD
Prednisolone—Pain—Progesterone—uterine cancer	0.000105	0.00231	CcSEcCtD
Prednisolone—ABCB1—mammalian vulva—uterine cancer	0.000105	0.00911	CbGeAlD
Prednisolone—Fluoxymesterone—ESR1—uterine cancer	0.000104	0.0751	CrCbGaD
Prednisolone—Testosterone—CYP11A1—uterine cancer	0.000102	0.0739	CrCbGaD
Prednisolone—Feeling abnormal—Progesterone—uterine cancer	0.000101	0.00223	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—uterine cancer	0.000101	0.00223	CcSEcCtD
Prednisolone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000101	0.00221	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—uterine cancer	0.0001	0.00221	CcSEcCtD
Prednisolone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	9.98e-05	0.0022	CcSEcCtD
Prednisolone—ABCB1—uterus—uterine cancer	9.96e-05	0.00868	CbGeAlD
Prednisolone—Herpes simplex—Doxorubicin—uterine cancer	9.9e-05	0.00218	CcSEcCtD
Prednisolone—Dexamethasone—CYP11A1—uterine cancer	9.89e-05	0.0715	CrCbGaD
Prednisolone—Hiccups—Epirubicin—uterine cancer	9.86e-05	0.00217	CcSEcCtD
Prednisolone—Ill-defined disorder—Dactinomycin—uterine cancer	9.85e-05	0.00217	CcSEcCtD
Prednisolone—NR3C1—lymph node—uterine cancer	9.79e-05	0.00852	CbGeAlD
Prednisolone—Urticaria—Progesterone—uterine cancer	9.74e-05	0.00215	CcSEcCtD
Prednisolone—Acute coronary syndrome—Etoposide—uterine cancer	9.7e-05	0.00214	CcSEcCtD
Prednisolone—Myocardial infarction—Etoposide—uterine cancer	9.64e-05	0.00212	CcSEcCtD
Prednisolone—Neuropathy peripheral—Etoposide—uterine cancer	9.64e-05	0.00212	CcSEcCtD
Prednisolone—Malaise—Dactinomycin—uterine cancer	9.58e-05	0.00211	CcSEcCtD
Prednisolone—Fluid retention—Epirubicin—uterine cancer	9.36e-05	0.00206	CcSEcCtD
Prednisolone—Neuropathy—Epirubicin—uterine cancer	9.25e-05	0.00204	CcSEcCtD
Prednisolone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	9.16e-05	0.00202	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—uterine cancer	9.12e-05	0.00201	CcSEcCtD
Prednisolone—Methyltestosterone—CYP19A1—uterine cancer	9.11e-05	0.0659	CrCbGaD
Prednisolone—Hypersensitivity—Progesterone—uterine cancer	9.04e-05	0.00199	CcSEcCtD
Prednisolone—ABCB1—female reproductive system—uterine cancer	8.96e-05	0.0078	CbGeAlD
Prednisolone—Discomfort—Dactinomycin—uterine cancer	8.93e-05	0.00197	CcSEcCtD
Prednisolone—Ecchymosis—Epirubicin—uterine cancer	8.91e-05	0.00196	CcSEcCtD
Prednisolone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	8.83e-05	0.00195	CcSEcCtD
Prednisolone—Betamethasone—CYP19A1—uterine cancer	8.79e-05	0.0636	CrCbGaD
Prednisolone—Pulmonary oedema—Epirubicin—uterine cancer	8.77e-05	0.00193	CcSEcCtD
Prednisolone—Oedema—Dactinomycin—uterine cancer	8.67e-05	0.00191	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—uterine cancer	8.66e-05	0.00191	CcSEcCtD
Prednisolone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	8.57e-05	0.0255	CbGpPWpGaD
Prednisolone—Neuropathy—Doxorubicin—uterine cancer	8.56e-05	0.00189	CcSEcCtD
Prednisolone—Thrombophlebitis—Epirubicin—uterine cancer	8.27e-05	0.00182	CcSEcCtD
Prednisolone—SLCO1A2—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	8.25e-05	0.0245	CbGpPWpGaD
Prednisolone—Ecchymosis—Doxorubicin—uterine cancer	8.25e-05	0.00182	CcSEcCtD
Prednisolone—Diabetes mellitus—Epirubicin—uterine cancer	8.23e-05	0.00181	CcSEcCtD
Prednisolone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	8.19e-05	0.0018	CcSEcCtD
Prednisolone—Progesterone—PGR—uterine cancer	8.15e-05	0.059	CrCbGaD
Prednisolone—ABCB1—female gonad—uterine cancer	8.15e-05	0.0071	CbGeAlD
Prednisolone—Pulmonary oedema—Doxorubicin—uterine cancer	8.12e-05	0.00179	CcSEcCtD
Prednisolone—Dizziness—Progesterone—uterine cancer	8.11e-05	0.00179	CcSEcCtD
Prednisolone—ABCB1—vagina—uterine cancer	8.1e-05	0.00705	CbGeAlD
Prednisolone—Cardiac failure congestive—Epirubicin—uterine cancer	7.89e-05	0.00174	CcSEcCtD
Prednisolone—Rash—Progesterone—uterine cancer	7.73e-05	0.0017	CcSEcCtD
Prednisolone—Dermatitis—Progesterone—uterine cancer	7.73e-05	0.0017	CcSEcCtD
Prednisolone—Headache—Progesterone—uterine cancer	7.68e-05	0.00169	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—uterine cancer	7.65e-05	0.00169	CcSEcCtD
Prednisolone—Increased appetite—Epirubicin—uterine cancer	7.62e-05	0.00168	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—uterine cancer	7.61e-05	0.00168	CcSEcCtD
Prednisolone—Dermatitis bullous—Epirubicin—uterine cancer	7.49e-05	0.00165	CcSEcCtD
Prednisolone—Dexamethasone—PGR—uterine cancer	7.45e-05	0.0539	CrCbGaD
Prednisolone—Pain—Dactinomycin—uterine cancer	7.41e-05	0.00163	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Epirubicin—uterine cancer	7.39e-05	0.00163	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—RRM2—uterine cancer	7.37e-05	0.0219	CbGpPWpGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—ESR1—uterine cancer	7.35e-05	0.0219	CbGpPWpGaD
Prednisolone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	7.35e-05	0.00162	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—uterine cancer	7.3e-05	0.00161	CcSEcCtD
Prednisolone—Nausea—Progesterone—uterine cancer	7.28e-05	0.00161	CcSEcCtD
Prednisolone—Osteoarthritis—Epirubicin—uterine cancer	7.16e-05	0.00158	CcSEcCtD
Prednisolone—Feeling abnormal—Dactinomycin—uterine cancer	7.14e-05	0.00157	CcSEcCtD
Prednisolone—Ill-defined disorder—Etoposide—uterine cancer	7.13e-05	0.00157	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—uterine cancer	7.05e-05	0.00155	CcSEcCtD
Prednisolone—Affect lability—Epirubicin—uterine cancer	7.04e-05	0.00155	CcSEcCtD
Prednisolone—Rash—Medroxyprogesterone Acetate—uterine cancer	7.01e-05	0.00154	CcSEcCtD
Prednisolone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	7e-05	0.00154	CcSEcCtD
Prednisolone—Headache—Medroxyprogesterone Acetate—uterine cancer	6.96e-05	0.00153	CcSEcCtD
Prednisolone—Malaise—Etoposide—uterine cancer	6.93e-05	0.00153	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—uterine cancer	6.93e-05	0.00153	CcSEcCtD
Prednisolone—Vertigo—Etoposide—uterine cancer	6.91e-05	0.00152	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—uterine cancer	6.84e-05	0.00151	CcSEcCtD
Prednisolone—Cardiac arrest—Epirubicin—uterine cancer	6.8e-05	0.0015	CcSEcCtD
Prednisolone—Mood swings—Epirubicin—uterine cancer	6.78e-05	0.00149	CcSEcCtD
Prednisolone—Loss of consciousness—Etoposide—uterine cancer	6.76e-05	0.00149	CcSEcCtD
Prednisolone—Convulsion—Etoposide—uterine cancer	6.66e-05	0.00147	CcSEcCtD
Prednisolone—Hypertension—Etoposide—uterine cancer	6.64e-05	0.00146	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—uterine cancer	6.62e-05	0.00146	CcSEcCtD
Prednisolone—Nausea—Medroxyprogesterone Acetate—uterine cancer	6.6e-05	0.00145	CcSEcCtD
Prednisolone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	6.6e-05	0.0196	CbGpPWpGaD
Prednisolone—Dry skin—Epirubicin—uterine cancer	6.56e-05	0.00145	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—uterine cancer	6.52e-05	0.00144	CcSEcCtD
Prednisolone—Discomfort—Etoposide—uterine cancer	6.47e-05	0.00142	CcSEcCtD
Prednisolone—Hypersensitivity—Dactinomycin—uterine cancer	6.39e-05	0.00141	CcSEcCtD
Prednisolone—Muscular weakness—Epirubicin—uterine cancer	6.31e-05	0.00139	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—uterine cancer	6.3e-05	0.00139	CcSEcCtD
Prednisolone—Anaphylactic shock—Etoposide—uterine cancer	6.27e-05	0.00138	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—uterine cancer	6.27e-05	0.00138	CcSEcCtD
Prednisolone—ABCB1—ABC-family proteins mediated transport—ABCC9—uterine cancer	6.25e-05	0.0186	CbGpPWpGaD
Prednisolone—Abdominal distension—Epirubicin—uterine cancer	6.23e-05	0.00137	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—PGR—uterine cancer	6.14e-05	0.0182	CbGpPWpGaD
Prednisolone—Tachycardia—Etoposide—uterine cancer	6.12e-05	0.00135	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—uterine cancer	6.07e-05	0.00134	CcSEcCtD
Prednisolone—Hyperhidrosis—Etoposide—uterine cancer	6.06e-05	0.00134	CcSEcCtD
Prednisolone—Pancreatitis—Epirubicin—uterine cancer	6.06e-05	0.00134	CcSEcCtD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	5.85e-05	0.0174	CbGpPWpGaD
Prednisolone—Muscular weakness—Doxorubicin—uterine cancer	5.84e-05	0.00129	CcSEcCtD
Prednisolone—NR3C2—Preimplantation Embryo—CDH1—uterine cancer	5.77e-05	0.0172	CbGpPWpGaD
Prednisolone—Abdominal distension—Doxorubicin—uterine cancer	5.76e-05	0.00127	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—HNF1B—uterine cancer	5.7e-05	0.0169	CbGpPWpGaD
Prednisolone—Paraesthesia—Etoposide—uterine cancer	5.63e-05	0.00124	CcSEcCtD
Prednisolone—Weight increased—Epirubicin—uterine cancer	5.63e-05	0.00124	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—uterine cancer	5.61e-05	0.00124	CcSEcCtD
Prednisolone—Rash—Dactinomycin—uterine cancer	5.47e-05	0.0012	CcSEcCtD
Prednisolone—Neuropathy peripheral—Epirubicin—uterine cancer	5.4e-05	0.00119	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptors—ESR2—uterine cancer	5.4e-05	0.0161	CbGpPWpGaD
Prednisolone—Pain—Etoposide—uterine cancer	5.36e-05	0.00118	CcSEcCtD
Prednisolone—Conjunctivitis—Epirubicin—uterine cancer	5.36e-05	0.00118	CcSEcCtD
Prednisolone—Testosterone—CYP19A1—uterine cancer	5.28e-05	0.0382	CrCbGaD
Prednisolone—ABCB1—lymph node—uterine cancer	5.24e-05	0.00456	CbGeAlD
Prednisolone—Weight increased—Doxorubicin—uterine cancer	5.21e-05	0.00115	CcSEcCtD
Prednisolone—Feeling abnormal—Etoposide—uterine cancer	5.17e-05	0.00114	CcSEcCtD
Prednisolone—Nausea—Dactinomycin—uterine cancer	5.15e-05	0.00113	CcSEcCtD
Prednisolone—Progesterone—ESR1—uterine cancer	5.14e-05	0.0372	CrCbGaD
Prednisolone—Dexamethasone—CYP19A1—uterine cancer	5.11e-05	0.037	CrCbGaD
Prednisolone—Bradycardia—Epirubicin—uterine cancer	5.04e-05	0.00111	CcSEcCtD
Prednisolone—Neuropathy peripheral—Doxorubicin—uterine cancer	5e-05	0.0011	CcSEcCtD
Prednisolone—Urticaria—Etoposide—uterine cancer	4.98e-05	0.0011	CcSEcCtD
Prednisolone—Haemoglobin—Epirubicin—uterine cancer	4.98e-05	0.0011	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—uterine cancer	4.96e-05	0.00109	CcSEcCtD
Prednisolone—Haemorrhage—Epirubicin—uterine cancer	4.95e-05	0.00109	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—PGR—uterine cancer	4.85e-05	0.0144	CbGpPWpGaD
Prednisolone—Visual impairment—Epirubicin—uterine cancer	4.77e-05	0.00105	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—uterine cancer	4.66e-05	0.00103	CcSEcCtD
Prednisolone—Hypersensitivity—Etoposide—uterine cancer	4.62e-05	0.00102	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—uterine cancer	4.6e-05	0.00101	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—uterine cancer	4.58e-05	0.00101	CcSEcCtD
Prednisolone—Arrhythmia—Epirubicin—uterine cancer	4.42e-05	0.000974	CcSEcCtD
Prednisolone—Visual impairment—Doxorubicin—uterine cancer	4.41e-05	0.000973	CcSEcCtD
Prednisolone—Erythema—Epirubicin—uterine cancer	4.31e-05	0.00095	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	4.27e-05	0.0127	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	4.18e-05	0.0124	CbGpPWpGaD
Prednisolone—Dizziness—Etoposide—uterine cancer	4.15e-05	0.000914	CcSEcCtD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	4.12e-05	0.0122	CbGpPWpGaD
Prednisolone—Arrhythmia—Doxorubicin—uterine cancer	4.09e-05	0.000902	CcSEcCtD
Prednisolone—Vision blurred—Epirubicin—uterine cancer	4.06e-05	0.000895	CcSEcCtD
Prednisolone—Ill-defined disorder—Epirubicin—uterine cancer	4e-05	0.000881	CcSEcCtD
Prednisolone—Erythema—Doxorubicin—uterine cancer	3.99e-05	0.000879	CcSEcCtD
Prednisolone—Rash—Etoposide—uterine cancer	3.96e-05	0.000872	CcSEcCtD
Prednisolone—Dermatitis—Etoposide—uterine cancer	3.95e-05	0.000871	CcSEcCtD
Prednisolone—Headache—Etoposide—uterine cancer	3.93e-05	0.000866	CcSEcCtD
Prednisolone—Malaise—Epirubicin—uterine cancer	3.89e-05	0.000856	CcSEcCtD
Prednisolone—Vertigo—Epirubicin—uterine cancer	3.87e-05	0.000853	CcSEcCtD
Prednisolone—Syncope—Epirubicin—uterine cancer	3.86e-05	0.000852	CcSEcCtD
Prednisolone—Loss of consciousness—Epirubicin—uterine cancer	3.79e-05	0.000835	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—uterine cancer	3.76e-05	0.000828	CcSEcCtD
Prednisolone—Convulsion—Epirubicin—uterine cancer	3.73e-05	0.000823	CcSEcCtD
Prednisolone—Nausea—Etoposide—uterine cancer	3.73e-05	0.000821	CcSEcCtD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—MTHFR—uterine cancer	3.73e-05	0.0111	CbGpPWpGaD
Prednisolone—Hypertension—Epirubicin—uterine cancer	3.72e-05	0.00082	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—uterine cancer	3.7e-05	0.000815	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—EZH2—uterine cancer	3.66e-05	0.0109	CbGpPWpGaD
Prednisolone—Discomfort—Epirubicin—uterine cancer	3.62e-05	0.000799	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—uterine cancer	3.6e-05	0.000792	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—uterine cancer	3.58e-05	0.000789	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—uterine cancer	3.58e-05	0.000788	CcSEcCtD
Prednisolone—Anaphylactic shock—Epirubicin—uterine cancer	3.52e-05	0.000775	CcSEcCtD
Prednisolone—Oedema—Epirubicin—uterine cancer	3.52e-05	0.000775	CcSEcCtD
Prednisolone—Loss of consciousness—Doxorubicin—uterine cancer	3.5e-05	0.000772	CcSEcCtD
Prednisolone—Shock—Epirubicin—uterine cancer	3.46e-05	0.000762	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—uterine cancer	3.45e-05	0.000761	CcSEcCtD
Prednisolone—Hypertension—Doxorubicin—uterine cancer	3.44e-05	0.000759	CcSEcCtD
Prednisolone—Tachycardia—Epirubicin—uterine cancer	3.43e-05	0.000756	CcSEcCtD
Prednisolone—Hyperhidrosis—Epirubicin—uterine cancer	3.4e-05	0.000749	CcSEcCtD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.39e-05	0.0101	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IRF1—uterine cancer	3.38e-05	0.0101	CbGpPWpGaD
Prednisolone—Discomfort—Doxorubicin—uterine cancer	3.35e-05	0.000739	CcSEcCtD
Prednisolone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	3.34e-05	0.00993	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—ESR1—uterine cancer	3.28e-05	0.00974	CbGpPWpGaD
Prednisolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	3.28e-05	0.00974	CbGpPWpGaD
Prednisolone—Oedema—Doxorubicin—uterine cancer	3.25e-05	0.000717	CcSEcCtD
Prednisolone—Anaphylactic shock—Doxorubicin—uterine cancer	3.25e-05	0.000717	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—PHF1—uterine cancer	3.23e-05	0.00959	CbGpPWpGaD
Prednisolone—Shock—Doxorubicin—uterine cancer	3.2e-05	0.000705	CcSEcCtD
Prednisolone—Insomnia—Epirubicin—uterine cancer	3.18e-05	0.000701	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—uterine cancer	3.18e-05	0.0007	CcSEcCtD
Prednisolone—Paraesthesia—Epirubicin—uterine cancer	3.16e-05	0.000696	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—uterine cancer	3.15e-05	0.000693	CcSEcCtD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.07e-05	0.00913	CbGpPWpGaD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.03e-05	0.00901	CbGpPWpGaD
Prednisolone—Pain—Epirubicin—uterine cancer	3.01e-05	0.000663	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—uterine cancer	2.94e-05	0.000649	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—uterine cancer	2.92e-05	0.000644	CcSEcCtD
Prednisolone—Feeling abnormal—Epirubicin—uterine cancer	2.9e-05	0.000639	CcSEcCtD
Prednisolone—Urticaria—Epirubicin—uterine cancer	2.79e-05	0.000616	CcSEcCtD
Prednisolone—Pain—Doxorubicin—uterine cancer	2.78e-05	0.000613	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—CHD4—uterine cancer	2.74e-05	0.00816	CbGpPWpGaD
Prednisolone—Feeling abnormal—Doxorubicin—uterine cancer	2.68e-05	0.000591	CcSEcCtD
Prednisolone—Hypersensitivity—Epirubicin—uterine cancer	2.59e-05	0.000571	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—uterine cancer	2.59e-05	0.00769	CbGpPWpGaD
Prednisolone—Urticaria—Doxorubicin—uterine cancer	2.58e-05	0.00057	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—SMAD3—uterine cancer	2.52e-05	0.00749	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.49e-05	0.0074	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	2.4e-05	0.00713	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	2.4e-05	0.00713	CbGpPWpGaD
Prednisolone—Hypersensitivity—Doxorubicin—uterine cancer	2.4e-05	0.000528	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—PGR—uterine cancer	2.38e-05	0.00707	CbGpPWpGaD
Prednisolone—Dizziness—Epirubicin—uterine cancer	2.33e-05	0.000512	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—NFE2L2—uterine cancer	2.31e-05	0.00688	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—SUZ12—uterine cancer	2.3e-05	0.00684	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—HMGA1—uterine cancer	2.29e-05	0.00682	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.22e-05	0.0066	CbGpPWpGaD
Prednisolone—Rash—Epirubicin—uterine cancer	2.22e-05	0.000489	CcSEcCtD
Prednisolone—Dermatitis—Epirubicin—uterine cancer	2.22e-05	0.000488	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—GPX3—uterine cancer	2.21e-05	0.00656	CbGpPWpGaD
Prednisolone—Headache—Epirubicin—uterine cancer	2.2e-05	0.000485	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	2.19e-05	0.00651	CbGpPWpGaD
Prednisolone—Dizziness—Doxorubicin—uterine cancer	2.15e-05	0.000474	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR2—uterine cancer	2.09e-05	0.00622	CbGpPWpGaD
Prednisolone—Nausea—Epirubicin—uterine cancer	2.09e-05	0.00046	CcSEcCtD
Prednisolone—Rash—Doxorubicin—uterine cancer	2.05e-05	0.000452	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—uterine cancer	2.05e-05	0.000452	CcSEcCtD
Prednisolone—Headache—Doxorubicin—uterine cancer	2.04e-05	0.000449	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—ESR1—uterine cancer	2.01e-05	0.00597	CbGpPWpGaD
Prednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—uterine cancer	2e-05	0.00594	CbGpPWpGaD
Prednisolone—Nausea—Doxorubicin—uterine cancer	1.93e-05	0.000426	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	1.89e-05	0.00562	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	1.8e-05	0.00534	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—uterine cancer	1.79e-05	0.00531	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCL2—uterine cancer	1.77e-05	0.00526	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—ESR2—uterine cancer	1.75e-05	0.00519	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—SOCS3—uterine cancer	1.72e-05	0.0051	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—CDKN2B—uterine cancer	1.7e-05	0.00507	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.6e-05	0.00477	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.6e-05	0.00477	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—SMAD3—uterine cancer	1.56e-05	0.00463	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—uterine cancer	1.54e-05	0.00458	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	1.53e-05	0.00455	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.53e-05	0.00453	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	1.51e-05	0.00449	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—SMAD3—uterine cancer	1.5e-05	0.00446	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of Androgen receptor activity—EP300—uterine cancer	1.5e-05	0.00445	CbGpPWpGaD
Prednisolone—NR3C1—Circadian Clock—EP300—uterine cancer	1.45e-05	0.00432	CbGpPWpGaD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	1.41e-05	0.0042	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CXCL8—uterine cancer	1.4e-05	0.00416	CbGpPWpGaD
Prednisolone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.39e-05	0.00414	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	1.39e-05	0.00412	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	1.37e-05	0.00406	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	1.34e-05	0.00399	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	1.32e-05	0.00393	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	1.32e-05	0.00393	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	1.29e-05	0.00384	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	1.27e-05	0.00378	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	1.26e-05	0.00374	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.24e-05	0.00369	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	1.23e-05	0.00366	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	1.2e-05	0.00356	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.18e-05	0.0035	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.17e-05	0.00347	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PGR—uterine cancer	1.15e-05	0.0034	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PHF1—uterine cancer	1.14e-05	0.00338	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.13e-05	0.00335	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.11e-05	0.0033	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—EZH2—uterine cancer	1.09e-05	0.00323	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.09e-05	0.00323	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.07e-05	0.00317	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	1.06e-05	0.00314	CbGpPWpGaD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	1.05e-05	0.00312	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR2—uterine cancer	1.01e-05	0.003	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SRD5A2—uterine cancer	9.88e-06	0.00294	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NDUFB11—uterine cancer	9.88e-06	0.00294	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	9.76e-06	0.0029	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CHD4—uterine cancer	9.66e-06	0.00287	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.6e-06	0.00285	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.13e-06	0.00271	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.07e-06	0.00269	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	8.6e-06	0.00256	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	8.58e-06	0.00255	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	8.38e-06	0.00249	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—CDKN2B—uterine cancer	8.21e-06	0.00244	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SUZ12—uterine cancer	8.1e-06	0.00241	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.98e-06	0.00237	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	7.97e-06	0.00237	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	7.86e-06	0.00234	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	7.56e-06	0.00225	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—SMAD3—uterine cancer	7.49e-06	0.00223	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	7.37e-06	0.00219	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	7.37e-06	0.00219	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	7.24e-06	0.00215	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—STAR—uterine cancer	7.15e-06	0.00212	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKR1B1—uterine cancer	7.15e-06	0.00212	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NDUFB11—uterine cancer	7.11e-06	0.00211	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SRD5A2—uterine cancer	7.11e-06	0.00211	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.06e-06	0.0021	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	7e-06	0.00208	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	6.82e-06	0.00203	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	6.8e-06	0.00202	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	6.75e-06	0.00201	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	6.59e-06	0.00196	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.53e-06	0.00194	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	6.5e-06	0.00193	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	6.49e-06	0.00193	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	6.45e-06	0.00192	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	6.4e-06	0.0019	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	6.39e-06	0.0019	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	6.32e-06	0.00188	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	6.14e-06	0.00183	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ESR1—uterine cancer	6.12e-06	0.00182	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	6e-06	0.00178	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	5.98e-06	0.00178	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—POLD1—uterine cancer	5.61e-06	0.00167	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	5.54e-06	0.00165	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	5.48e-06	0.00163	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKR1C1—uterine cancer	5.24e-06	0.00156	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKR1B1—uterine cancer	5.14e-06	0.00153	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—STAR—uterine cancer	5.14e-06	0.00153	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.85e-06	0.00144	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.84e-06	0.00144	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.78e-06	0.00142	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—RRM2—uterine cancer	4.67e-06	0.00139	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—DCN—uterine cancer	4.54e-06	0.00135	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	4.47e-06	0.00133	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP11A1—uterine cancer	4.28e-06	0.00127	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SRD5A2—uterine cancer	4.23e-06	0.00126	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NDUFB11—uterine cancer	4.23e-06	0.00126	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.08e-06	0.00121	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKR1C3—uterine cancer	4.04e-06	0.0012	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—POLD1—uterine cancer	4.03e-06	0.0012	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PGR—uterine cancer	4.03e-06	0.0012	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—EZH2—uterine cancer	3.83e-06	0.00114	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKR1C1—uterine cancer	3.77e-06	0.00112	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR2—uterine cancer	3.55e-06	0.00106	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.55e-06	0.00105	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RRM2—uterine cancer	3.36e-06	0.000999	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.29e-06	0.000977	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—DCN—uterine cancer	3.26e-06	0.00097	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—STK11—uterine cancer	3.15e-06	0.000935	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	3.15e-06	0.000935	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.11e-06	0.000923	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP11A1—uterine cancer	3.08e-06	0.000914	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKR1B1—uterine cancer	3.06e-06	0.000909	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—STAR—uterine cancer	3.06e-06	0.000909	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.03e-06	0.0009	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.95e-06	0.000878	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.9e-06	0.000863	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CDKN2B—uterine cancer	2.89e-06	0.000859	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.89e-06	0.000858	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.82e-06	0.000837	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.73e-06	0.000813	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SMAD3—uterine cancer	2.64e-06	0.000784	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.61e-06	0.000775	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.61e-06	0.000775	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—POLD1—uterine cancer	2.4e-06	0.000713	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.36e-06	0.000702	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.32e-06	0.000691	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—STK11—uterine cancer	2.26e-06	0.000672	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP19A1—uterine cancer	2.26e-06	0.000672	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKR1C1—uterine cancer	2.25e-06	0.000667	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—AKT1—uterine cancer	2.21e-06	0.000656	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ESR1—uterine cancer	2.15e-06	0.00064	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.14e-06	0.000635	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.08e-06	0.000619	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.07e-06	0.000614	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RRM2—uterine cancer	2e-06	0.000595	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—DCN—uterine cancer	1.94e-06	0.000577	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.88e-06	0.00056	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—STAR—uterine cancer	1.88e-06	0.00056	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP11A1—uterine cancer	1.83e-06	0.000544	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.74e-06	0.000518	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKR1C3—uterine cancer	1.73e-06	0.000514	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—MTHFR—uterine cancer	1.7e-06	0.000505	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—POLD1—uterine cancer	1.48e-06	0.00044	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.38e-06	0.000411	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP19A1—uterine cancer	1.35e-06	0.0004	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—STK11—uterine cancer	1.35e-06	0.0004	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTEN—uterine cancer	1.31e-06	0.000391	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—EP300—uterine cancer	1.25e-06	0.000373	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RRM2—uterine cancer	1.23e-06	0.000366	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—DCN—uterine cancer	1.2e-06	0.000356	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.13e-06	0.000335	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.06e-06	0.000316	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—MTHFR—uterine cancer	1.01e-06	0.000301	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTEN—uterine cancer	9.46e-07	0.000281	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	9.28e-07	0.000276	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—EP300—uterine cancer	9.02e-07	0.000268	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—STK11—uterine cancer	8.3e-07	0.000247	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP19A1—uterine cancer	8.3e-07	0.000247	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—AKT1—uterine cancer	7.77e-07	0.000231	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—AKT1—uterine cancer	7.58e-07	0.000225	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CA—uterine cancer	6.67e-07	0.000198	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—MTHFR—uterine cancer	6.23e-07	0.000185	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTEN—uterine cancer	5.63e-07	0.000167	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—AKT1—uterine cancer	5.45e-07	0.000162	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—EP300—uterine cancer	5.37e-07	0.00016	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CA—uterine cancer	3.97e-07	0.000118	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTEN—uterine cancer	3.47e-07	0.000103	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—EP300—uterine cancer	3.31e-07	9.83e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—AKT1—uterine cancer	3.24e-07	9.64e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.45e-07	7.27e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—AKT1—uterine cancer	2e-07	5.94e-05	CbGpPWpGaD
